Merus NV (MRUS)
59.99
+15.92
(+36.12%)
USD |
NASDAQ |
May 24, 16:00
59.99
0.00 (0.00%)
After-Hours: 17:07
Merus Cash from Operations (Quarterly): -44.39M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -44.39M |
| December 31, 2023 | -36.35M |
| September 30, 2023 | -27.53M |
| June 30, 2023 | -41.59M |
| March 31, 2023 | -36.74M |
| December 31, 2022 | -30.51M |
| September 30, 2022 | -41.26M |
| June 30, 2022 | -31.73M |
| March 31, 2022 | -46.40M |
| December 31, 2021 | -31.60M |
| September 30, 2021 | -23.08M |
| June 30, 2021 | -24.30M |
| March 31, 2021 | 19.34M |
| December 31, 2020 | -24.34M |
| September 30, 2020 | -11.70M |
| June 30, 2020 | -18.61M |
| March 31, 2020 | -25.26M |
| December 31, 2019 | -19.74M |
| September 30, 2019 | -14.02M |
| Date | Value |
|---|---|
| June 30, 2019 | -15.77M |
| March 31, 2019 | -13.51M |
| December 31, 2018 | -10.38M |
| September 30, 2018 | -18.22M |
| June 30, 2018 | -1.445M |
| March 31, 2018 | -16.05M |
| December 31, 2017 | -11.81M |
| September 30, 2017 | -15.26M |
| June 30, 2017 | -10.86M |
| March 31, 2017 | -6.955M |
| December 31, 2016 | -8.105M |
| September 30, 2016 | -5.267M |
| June 30, 2016 | -6.096M |
| March 31, 2016 | -7.596M |
| December 31, 2015 | -7.634M |
| September 30, 2015 | -8.366M |
| June 30, 2015 | -4.373M |
| March 31, 2015 | -4.807M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-46.40M
Minimum
Mar 2022
19.34M
Maximum
Mar 2021
-26.28M
Average
-26.40M
Median
Cash from Operations (Quarterly) Benchmarks
| uniQure NV | -60.58M |
| ProQR Therapeutics NV | -16.44M |
| argenx SE | -- |
| Pharming Group | -7.647M |
| Pharvaris NV | -26.32M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -12.08M |
| Cash from Financing (Quarterly) | 30.16M |
| Free Cash Flow | -150.28M |
| Free Cash Flow Per Share (Quarterly) | -0.7653 |
| Free Cash Flow to Equity (Quarterly) | -44.45M |
| Free Cash Flow to Firm (Quarterly) | -44.45M |
| Free Cash Flow Yield | -4.59% |